Metraipolis › archive › dc_aa428de407c2
Progress in Anti-Obesity Drug Development: A Pharmacodynamics Perspective — Europe PMC PMID:42942813
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42942813
- DOI
- 10.3390/pharmaceutics18101281
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T00:19:45.499Z
- SHA-256 of the archived text
3367c7ac457a4aa457ab0a543424548929d33c5a1261f3b522b512212ee287eb- Stable URL of this page
https://metraipolis.com/documento/dc_aa428de407c2
How to cite
Progress in Anti-Obesity Drug Development: A Pharmacodynamics Perspective — Europe PMC PMID:42942813 — Europe PMC (en), https://europepmc.org/article/MED/42942813 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aa428de407c2 (Metraipolis archive dc_aa428de407c2, sha256 3367c7ac457a4aa457ab0a543424548929d33c5a1261f3b522b512212ee287eb)
BibTeX
@misc{dcaa428de407c2,
title = {Progress in Anti-Obesity Drug Development: A Pharmacodynamics Perspective — Europe PMC PMID:42942813},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42942813},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aa428de407c2; sha256 3367c7ac457a4aa457ab0a543424548929d33c5a1261f3b522b512212ee287eb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42942813. Agents can read the archived copy with the MCP tool read_document.